Producing modified allergen extracts
for therapeutic and diagnostic purpose
HAL Allergy is one of the European top players in the development, production and distribution of allergen immunotherapies for the treatment and prevention of allergic diseases. With a highly competitive product portfolio, including subcutaneous and sublingual products, and a future-oriented pipeline portfolio, HAL Allergy strives to provide the best possible medical products and scientific output. HAL Allergy is located in the Bio Science Park in Leiden, The Netherlands.